Aclaris Therapeutics, Inc.

UBS Group AG ACRS

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

362,538

Value ($000)

1,091

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	1,091	0.0%	362,538	12/31/2025
2025 Q3	11/13/2025	200	0.0%	105,138	9/30/2025
2025 Q2	8/14/2025	218	0.0%	153,172	6/30/2025
2025 Q1	5/13/2025	113	0.0%	73,992	3/31/2025
2024 Q4	2/14/2025	172	0.0%	69,463	12/31/2024
2024 Q3	11/14/2024	37	0.0%	31,852	9/30/2024
2024 Q2	8/14/2024	37	0.0%	33,791	6/30/2024
2024 Q1	5/13/2024	87	0.0%	70,401	3/31/2024
2023 Q4	2/9/2024	21	0.0%	19,624	12/31/2023
2023 Q3	11/9/2023	354	0.0%	51,678	9/30/2023
2023 Q2	8/11/2023	29	0.0%	2,814	6/30/2023
2023 Q1	5/12/2023	16	0.0%	2,033	3/31/2023
2022 Q4	2/8/2023	38	0.0%	2,406	12/31/2022
2022 Q3	11/10/2022	45	0.0%	2,871	9/30/2022
2022 Q2	8/10/2022	34	0.0%	2,406	6/30/2022
2022 Q1	5/16/2022	29	0.0%	1,702	3/31/2022
2021 Q4	2/14/2022	671	0.0%	46,188	12/31/2021
2021 Q3	11/15/2021	30	0.0%	1,650	9/30/2021
2021 Q2	8/13/2021	51	0.0%	2,899	6/30/2021
2021 Q1	5/12/2021	160	0.0%	6,366	3/31/2021
2020 Q4	2/11/2021	8	0.0%	1,306	12/31/2020
2020 Q3	11/12/2020	13	0.0%	5,016	9/30/2020
2020 Q2	7/31/2020	1	0.0%	547	6/30/2020
2020 Q1	5/1/2020	20	0.0%	18,997	3/31/2020
2019 Q4	2/14/2020	71	0.0%	37,806	12/31/2019